Product Code: ETC6190096 | Publication Date: Sep 2024 | Updated Date: Jun 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Treatment options for RDS in Australia primarily include surfactant therapy, mechanical ventilation, CPAP, and corticosteroids for preterm births. Government investments in neonatal healthcare infrastructure and increasing adoption of less invasive surfactant administration techniques are enhancing patient outcomes and expanding the market for RDS treatment.
Treatment options for RDS in Australia are advancing through innovations in surfactants and mechanical ventilation. Non-invasive techniques like CPAP (Continuous Positive Airway Pressure) are gaining popularity. Government focus on improving neonatal and pediatric healthcare infrastructure also drives market support.
Treating RDS involves costly interventions such as ventilators and surfactant therapies, which are not always accessible in rural health settings. Resistance to certain treatments and the need for timely diagnosis further complicate patient management strategies.
Investment in this segment is closely linked to advancements in pediatric and neonatal care. Opportunities abound in developing targeted pharmaceuticals, such as surfactant replacement therapies and corticosteroids, as well as improved ventilator technologies. Collaborations with public hospitals and research institutions further support innovation and clinical trials in this space.
This market is supported by specific reimbursement policies under Medicare for critical care services and associated pharmacological treatments. Government-funded clinical trials and research programs often focus on advancing treatment protocols for RDS, and TGA approval is mandatory for surfactant therapies and mechanical ventilation systems used in treatment.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Respiratory Distress Syndrome Treatment Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Respiratory Distress Syndrome Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Respiratory Distress Syndrome Treatment Market - Industry Life Cycle |
3.4 Australia Respiratory Distress Syndrome Treatment Market - Porter's Five Forces |
3.5 Australia Respiratory Distress Syndrome Treatment Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 Australia Respiratory Distress Syndrome Treatment Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.7 Australia Respiratory Distress Syndrome Treatment Market Revenues & Volume Share, By End users, 2021 & 2031F |
3.8 Australia Respiratory Distress Syndrome Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Respiratory Distress Syndrome Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Respiratory Distress Syndrome Treatment Market Trends |
6 Australia Respiratory Distress Syndrome Treatment Market, By Types |
6.1 Australia Respiratory Distress Syndrome Treatment Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 Australia Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 Australia Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Medication, 2021- 2031F |
6.1.4 Australia Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Therapy, 2021- 2031F |
6.1.5 Australia Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Australia Respiratory Distress Syndrome Treatment Market, By Administration |
6.2.1 Overview and Analysis |
6.2.2 Australia Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.2.3 Australia Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Inhalation, 2021- 2031F |
6.2.4 Australia Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Australia Respiratory Distress Syndrome Treatment Market, By End users |
6.3.1 Overview and Analysis |
6.3.2 Australia Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Australia Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Homecare, 2021- 2031F |
6.3.4 Australia Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Speciality Centers, 2021- 2031F |
6.3.5 Australia Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Australia Respiratory Distress Syndrome Treatment Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Australia Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Australia Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Online Pharmcy, 2021- 2031F |
6.4.4 Australia Respiratory Distress Syndrome Treatment Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Australia Respiratory Distress Syndrome Treatment Market Import-Export Trade Statistics |
7.1 Australia Respiratory Distress Syndrome Treatment Market Export to Major Countries |
7.2 Australia Respiratory Distress Syndrome Treatment Market Imports from Major Countries |
8 Australia Respiratory Distress Syndrome Treatment Market Key Performance Indicators |
9 Australia Respiratory Distress Syndrome Treatment Market - Opportunity Assessment |
9.1 Australia Respiratory Distress Syndrome Treatment Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 Australia Respiratory Distress Syndrome Treatment Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.3 Australia Respiratory Distress Syndrome Treatment Market Opportunity Assessment, By End users, 2021 & 2031F |
9.4 Australia Respiratory Distress Syndrome Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Respiratory Distress Syndrome Treatment Market - Competitive Landscape |
10.1 Australia Respiratory Distress Syndrome Treatment Market Revenue Share, By Companies, 2024 |
10.2 Australia Respiratory Distress Syndrome Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |